BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23142635)

  • 1. Developing and advancing dry powder inhalation towards enhanced therapeutics.
    Stegemann S; Kopp S; Borchard G; Shah VP; Senel S; Dubey R; Urbanetz N; Cittero M; Schoubben A; Hippchen C; Cade D; Fuglsang A; Morais J; Borgström L; Farshi F; Seyfang KH; Hermann R; van de Putte A; Klebovich I; Hincal A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):181-94. PubMed ID: 23142635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the future: inhaled drug products.
    Hickey AJ
    J Pharm Sci; 2013 Apr; 102(4):1165-72. PubMed ID: 23381932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery Technologies for Orally Inhaled Products: an Update.
    Moon C; Smyth HDC; Watts AB; Williams RO
    AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers.
    Islam N; Cleary MJ
    Med Eng Phys; 2012 May; 34(4):409-27. PubMed ID: 22277307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A novel pulmonary delivery system--dry powder inhalers].
    Tang Y; Zhu JB; Chen XJ
    Yao Xue Xue Bao; 2009 Jun; 44(6):571-4. PubMed ID: 19806884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.
    Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Löbenberg R
    Ther Deliv; 2011 Oct; 2(10):1313-24. PubMed ID: 22826885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for pulmonary delivery of high powder doses.
    Sibum I; Hagedoorn P; de Boer AH; Frijlink HW; Grasmeijer F
    Int J Pharm; 2018 Sep; 548(1):325-336. PubMed ID: 29991452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive lung-targeted drug delivery systems via intravenous administration.
    Wei Y; Zhao L
    Pharm Dev Technol; 2014 Mar; 19(2):129-36. PubMed ID: 23336716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device factors affecting pulmonary delivery of dry powders.
    Smutney CC; Grant M; Kinsey PS
    Ther Deliv; 2013 Aug; 4(8):939-49. PubMed ID: 23919473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model.
    Sinha B; Mukherjee B
    Drug Dev Ind Pharm; 2012 Feb; 38(2):171-9. PubMed ID: 21721851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of a dry powder inhaler: device design and optimisation.
    Friebel C; Steckel H; Müller BW
    J Pharm Pharmacol; 2012 Sep; 64(9):1303-15. PubMed ID: 22881442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation considerations for dry powder inhalers.
    Cordts E; Steckel H
    Ther Deliv; 2014 Jun; 5(6):675-89. PubMed ID: 25090281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel dry powder inhaler particle-dispersion systems.
    Donovan MJ; Gibbons A; Herpin MJ; Marek S; McGill SL; Smyth HD
    Ther Deliv; 2011 Oct; 2(10):1295-311. PubMed ID: 22826884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.